Akili Price to Sales Ratio 2022-2023 | AKLI

Historical PS ratio values for Akili (AKLI) over the last 10 years. The current P/S ratio for Akili as of May 03, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Akili P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-05-03 0.40 18.71
2023-12-31 0.49 $0.02 22.70
2023-09-30 0.55 $0.02 35.19
2023-06-30 1.11 $0.01 0.00
2023-03-31 1.60 $0.04 36.26
2022-12-31 1.12 $0.08 13.67
2022-09-30 2.26 $0.08 28.88
2022-06-30 9.89 $0.19 51.26
2022-03-31 9.89 $0.16 63.75
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.032B $0.002B
Akili Interactive is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies. The company's platform is powered by proprietary therapeutic engines designed to target cognitive impairment. Akili Interactive, formerly known as Roblox, is based in BOSTON, Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.527B 19.51
Inspire Medical Systems (INSP) United States $7.610B 0.00
IRhythm Technologies (IRTC) United States $3.451B 0.00
Axonics (AXNX) United States $3.424B 0.00
10x Genomics (TXG) United States $3.133B 0.00
Azenta (AZTA) United States $2.932B 238.96
Olink Holding AB (publ) (OLK) Sweden $2.862B 0.00
Enovis (ENOV) United States $2.859B 21.19
Hims & Hers Health (HIMS) United States $2.622B 0.00
Privia Health (PRVA) United States $2.184B 96.89
Schrodinger (SDGR) United States $1.677B 0.00
Omnicell (OMCL) United States $1.345B 46.49
Phreesia (PHR) United States $1.255B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.734B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.701B 0.00
Fulgent Genetics (FLGT) United States $0.635B 0.00
Talkspace (TALK) United States $0.531B 0.00
Health Catalyst (HCAT) United States $0.386B 0.00
Pulmonx (LUNG) United States $0.361B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.331B 0.00
Clover Health Investments (CLOV) United States $0.319B 0.00
Butterfly Network (BFLY) United States $0.192B 0.00
P3 Health Partners (PIII) United States $0.189B 0.00
Outset Medical (OM) United States $0.155B 0.00
American Well (AMWL) United States $0.151B 0.00
Augmedix (AUGX) United States $0.130B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
TruBridge (TBRG) United States $0.125B 5.32
111 (YI) China $0.094B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
NantHealth (NHIQ) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.056B 0.00
Movano (MOVE) United States $0.050B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00